This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This proposal will examine the central hypothesis that: The three commercially available parenteral iron formations produce significant oxidative stress in patients receiving hemodialysis and that the rate and extent of the appearance of markers of oxidative stress differs among the available formulations. 1) To compare the rate and extent of the appearance of acute markers of oxidative stress after single intravenous doses of iron dextran, sodium ferric gluconate, and iron sucrose. 2) To determine if differences exist in antibodies to oxLDL and C-reactive protein after administration of iron dextran, sodium ferric gluconate and iron sucrose.
Showing the most recent 10 out of 568 publications